Impact of hyper-polypharmacy due to non-cardiovascular medications on long-term clinical outcomes following endovascular treatment for lower limb artery disease: A sub-analysis of the I-PAD Nagano registry.
Kato T, Minamisawa M, Miura T, Kanai M, Oyama Y, Hashizume N, Yokota D, Taki M, Senda K, Nishikawa K, Wakabayashi T, Fujimori K, Karube K, Sakai T, Inoue M, Yoda H, Sunohara D, Okina Y, Nomi H, Kanzaki Y, Machida K, Kashiwagi D, Ueki Y, Saigusa T, Ebisawa S, Okada A, Motoki H, Kuwahara K; I-PAD Nagano Investigators.
Kato T, et al. Among authors: yoda h.
J Cardiol. 2024 Dec;84(6):379-387. doi: 10.1016/j.jjcc.2024.06.011. Epub 2024 Jul 2.
J Cardiol. 2024.
PMID: 38964712